Distance to glycemic goal at the time of treatment intensification in patients with type 2 diabetes mellitus failing metformin monotherapy in the United States

Gail FernandesCenter for Observational and Real-world Evidence, Merck and Co., Inc, Kenilworth, NJ, USA; Correspondence[email protected]

Baanie SawhneyComplete HEOR Solutions (CHEORS), North Wales, PA, USA;

Hakima HannachiCenter for Observational and Real-world Evidence, Merck and Co., Inc, Kenilworth, NJ, USA;

Jinan LiuCenter for Observational and Real-world Evidence, Merck and Co., Inc, Kenilworth, NJ, USA;

Tongtong WangCenter for Observational and Real-world Evidence, Merck and Co., Inc, Kenilworth, NJ, USA;

Alex Z. FuGeorgetown University Medical Center, WashingtonDC, USA

Kristy IglayCenter for Observational and Real-world Evidence, Merck and Co., Inc, Kenilworth, NJ, USA;

Annie McNeillCenter for Observational and Real-world Evidence, Merck and Co., Inc, Kenilworth, NJ, USA;

Swapnil RajpathakCenter for Observational and Real-world Evidence, Merck and Co., Inc, Kenilworth, NJ, USA;

Citations (7)

Keep up to date with the latest research on this topic with citation updates for this article.